<DOC>
	<DOCNO>NCT00977665</DOCNO>
	<brief_summary>To test clinical effect rasagiline subject MSA parkinsonian subtype .</brief_summary>
	<brief_title>Clinical Trial Assess Efficacy , Safety , Tolerability Rasagiline Mesylate 1 mg Patients With Multiple System Atrophy Parkinsonian Subtype ( MSA-P )</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Multiple System Atrophy</mesh_term>
	<mesh_term>Shy-Drager Syndrome</mesh_term>
	<mesh_term>Rasagiline</mesh_term>
	<criteria>Subjects 30 year old diagnosis Possible Probable MSA parkinsonian subtype ( MSAP ) accord The Gilman Criteria ( 2008 ) . Subjects less 3 year time document MSA diagnosis . Subjects anticipated survival least 3 year opinion investigator . Subjects willing able give inform consent . Subjects able write may give verbal consent presence least one witness , witness sign inform consent form . Subjects receive treatment midodrine sympathomimetics within 4 week prior baseline visit . Subjects severe orthostatic symptom assess score ≥ 3 Unified Multiple System Atrophy Rating Scale ( UMSARS ) question 9 . Subjects meet follow criterion tend suggest advanced disease : 1 . Speech impairment assess score ≥ 3 UMSARS question 1 2 . Swallowing impairment assess score ≥ 3 UMSARS question 2 3 . Impairment ambulation assess score ≥ 3 UMSARS question 7 4 . Falling frequently per week assess score ≥ 3 UMSARS question 8 Subjects take disallowed medication accord locally approve Azilect® label . Subjects take monoamine oxidase ( MAO ) inhibitor within 3 month prior baseline visit . Subjects hypertension whose blood pressure , investigator 's opinion , well control . Subjects , base investigator 's judgment , clinically significant unstable medical surgical condition may preclude safe complete study participation . Subjects moderate severe hepatic impairment . Subjects take investigational product within 60 day prior baseline . Women childbearing potential practice acceptable method birth control [ acceptable method birth control study : surgical sterilization , intrauterine device , oral contraceptive , contraceptive patch , longacting injectable contraceptive , partner 's vasectomy , doubleprotection method ( condom diaphragm spermicide ) ] . Pregnant nursing woman .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>